Chugai Pharma (United States)

872 papers and 19.6k indexed citations i.

About

In recent decades, authors affiliated with Chugai Pharma (United States) have published 872 papers, which have received a total of 19.6k indexed citations. Scholars at this organization have produced 294 papers in Molecular Biology, 134 papers in Oncology and 103 papers in Organic Chemistry on the topics of Monoclonal and Polyclonal Antibodies Research (62 papers), Glycosylation and Glycoproteins Research (39 papers) and Carbohydrate Chemistry and Synthesis (30 papers). Their work is cited by papers focused on Molecular Biology (6.4k citations), Oncology (3.7k citations) and Pulmonary and Respiratory Medicine (2.8k citations). Authors at Chugai Pharma (United States) collaborate with scholars in United States, Japan and United Kingdom and have published in prestigious journals including Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences. Some of Chugai Pharma (United States)'s most productive authors include Kunio Ando, Masahiko Mihara, Yoshiyuki Ohsugi, SEIKICHI SUZUKI, Kazuyuki Uchida, Norihiro Nishimoto, Gakuzo Tamura, Mikio Sawada, Hiroshi Okazaki and Kazushige Sakai.

In The Last Decade

Fields of papers published by authors at Chugai Pharma (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Chugai Pharma (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Chugai Pharma (United States) at the time of their publication.

Countries citing scholars working at Chugai Pharma (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Chugai Pharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Chugai Pharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chugai Pharma (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Epsom Hospital Breakdown of academic impact, for scholars at Truman Medical Center Breakdown of academic impact, for scholars at University of South Alabama Medical Center Breakdown of academic impact, for scholars at Hôpital André Mignot Breakdown of academic impact, for scholars at Swiss Centre for Scientific Research Breakdown of academic impact, for scholars at Institute of Zoology of the Slovak Academy of Sciences Breakdown of academic impact, for scholars at Epatocentro Ticino Breakdown of academic impact, for scholars at Technical University of Applied Sciences Wildau
Rankless by CCL
2025